CD8A and neoplasm: De Pillis et al. developed a mathematical model to replicate the experimental study of NKG2D ligand-transduced tumor cells, which boosts NK and CD8+ T cells activation, stimulates protective immunity as a vaccination, and causes tumor regression [61,62].